UPB
Upstream Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.34
+0.56%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 157.68x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.08x
- Price / sales
- 92.61x
- Price / cash flow
- -2.15x
Enterprise value
- Enterprise value
- $32.1M
- EV / sales
- 10.17x
- EV / EBITDA
- -0.21x
- EV / EBIT
- -0.19x
- Market cap
- $292.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026